by grtucker_adm | May 15, 2023 | Uncategorized
AQS Bio will attend Bio Boston from June 5-8, 2023
by grtucker_adm | May 15, 2023 | Uncategorized
AQS Bio becomes the first consulting company to assist with one of the first Global Licensing Agreement expansions, between a Japanese biopharma and a top 15 Chinese biopharma, for a novel clinical stage obesity asset.
by grtucker_adm | May 15, 2023 | Uncategorized
AQS Bio becomes the first consulting services company to orchestrate one of the first licensing agreements between a Japanese biopharma and a top 15 Chinese biopharma, for a novel clinical stage obesity asset, for the East Asia territory.
by grtucker_adm | May 15, 2023 | Uncategorized
AQS Bio assists one of the first Chinese biosimilar companies with an insulin drug approval in the EU.
by grtucker_adm | May 15, 2023 | Uncategorized
AQS Bio assists a top 10 Chinese biopharma factory with passing an FDA GMP inspection.
by grtucker_adm | May 15, 2023 | Uncategorized
AQS Bio provides validation assessment and GMP training services for Astra Zeneca, Shanghai China.
